Patent Assignment
Reel/Frame 032787/0263
Assignment of Assignor's Interest
Recorded: 2014-04-30
Pages: 5
Assignors
LONG, XIANGTIAN
Executed: 2012-05-08
DAI, DANMEI
Executed: 2012-05-08
BRUNNER, ANDREAS
Executed: 2012-05-10
Assignee
LONZA BIOLOGICS INC.
101 INTERNATIONAL DRIVE, PORTSMOUTH, NEW HAMPSHIRE, 03801
Covered Property
(1)
Methods for synthesizing molybdopterin precursor Z derivatives
Related Assignments
(14)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 30, 2014
From: WATT, DEREK KEVIN; CLINCH, KEITH; DIXON, RACHEL ANNE; BAARS, SYLVIA MYRNA
To: INDUSTRIAL RESEARCH LIMITED
Reel/Frame 032786/0969 →
Assignment of Assignor's Interest
Apr 30, 2014
From: ALEXION PHARMACEUTICALS, INC.
To: ALEXION PHARMA INTERNATIONAL SARL
Reel/Frame 032787/0586 →
Assignment of Assignor's Interest
Apr 30, 2014
From: LONZA BIOLOGICS INC.
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 032787/0520 →
Assignment of Assignor's Interest
Apr 30, 2014
From: SELCIA LIMITED
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 032787/0417 →
Assignment of Assignor's Interest
Apr 30, 2014
From: INDUSTRIAL RESEARCH LIMITED
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 032787/0356 →
Assignment of Assignor's Interest
Apr 30, 2014
From: PROISY, NICOLAS GEORGES RENE; LANDREAU, CYRILLE ABEL SEBASTIEN; LITTLE, GILLIAN MARY
To: SELICA LIMITED
Reel/Frame 032787/0188 →
Assignment of Assignor's Interest
Nov 12, 2014
From: ALEXION PHARMA INTERNATIONAL SARL
To: ALEXION PHARMA HOLDING
Reel/Frame 034156/0958 →
Assignment of Assignor's Interest
Jul 20, 2015
From: ALEXION PHARMA HOLDING
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 036132/0529 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 032787 Frame: 0188. Assignor(S) Hereby Confirms the Assignment.
Dec 10, 2015
From: PROISY, NICOLAS GEORGES RENE; LANDREAU, CYRILLE ABEL SEBASTIEN; LITTLE, GILLIAN MARY
To: SELCIA LIMITED
Reel/Frame 037267/0263 →
Assignment of Assignor's Interest
Feb 1, 2019
From: ALEXION PHARMACEUTICALS, INC.
To: ORIGIN BIOSCIENCES, INC.
Reel/Frame 048220/0548 →
Security Interest
Nov 17, 2021
From: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058144/0302 →
Release of Security Interest
Apr 12, 2022
From: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: ORIGIN BIOSCIENCES, INC.
Reel/Frame 059577/0483 →
Assignment of Assignor's Interest
Apr 21, 2022
From: ORIGIN BIOSCIENCES, INC.
To: SENTYNL THERAPEUTICS, INC.
Reel/Frame 059671/0674 →
Release of Security Interest
Jan 18, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR TO U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
Reel/Frame 066167/0462 →